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Abstract - May-Thurner syndrome (MTS) is an 
anatomically variable condition resulting in 
compression of the left common iliac vein between 
the right common iliac artery and the underlying 
spine with subsequent development of a left deep 
vein thrombosis (DVT). Although this syndrome is 
rare, its true prevalence is likely underestimated. 
Mainly, clinical symptoms and signs include, but are 
not limited to, pain, swelling, venous stasis ulcers, 
skin pigmentation changes and post-thrombotic 
syndrome. Correct treatment is not well established 
and is based on clinical presentation. Staged 
thrombolysis with/without prophylactic retrievable 
inferior vena cava filter placement followed by 
angioplasty/stenting of the left iliac vein appears to 
be the best option in MTS patients with extensive 
DVT. The aim of this review is to present in a simple 
and didactic form all variable clinical presentations 
of MTS and to outline possible management within 
the current guidelines. 
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 May-Thurner Syndrome (MTS), otherwise 
known as iliac vein compression syndrome [1], is an 
anatomically variable condition of the left common iliac 
vein (LCIV) with outflow obstruction caused by the right 
common iliac artery compression against the lower lumbar 
vertebrae (Fig.1). Right-sided MTS cases are definitively 
more rare but have also been reported [2,3] in the 
literature. The majority of patients with right-sided MTS 
are male which may be due to the shape of the male 
pelvis. Although numerous articles have described the 
left-sided and female predominance of MTS, no 
correlation has been found between right-sided MTS and 
male gender. Some Authors postulate that the conical 
shape of the male pelvis may predispose the right iliac 
vein to compression by the iliac artery. However Virchow 
was the first who described this condition in 1851 and 
noted that deep vein thrombosis (DVT) was five times 
more likely to occur in the left lower limb [4]. In 1906 
Mcmurrich proposed a congenital aetiology for LCVI 
obstruction [5] while Ehrich and Krumbhaar postulated, 
instead, a degenerative change of a venous valve at or near 
the origin of the LCIV [6]. Compression of the left iliac 
vein with detailed anatomic description was later 
described by May and Thurner in 1958 [7]. Cockett and 
Thomas also reported this condition in 1965, illustrating 
the relation between iliac vein compression and post-
thrombotic syndrome and for this reason it is also known 
as “Cockett syndrome” [1]. Compression of the left 
common iliac vein by the right common iliac artery is a 
frequent anatomic variant observed in 22-32% of cadavers 
[8]. Most MTS patients throughout the course of their 
lives have no symptoms and therefore no treatment is 
required. Some Authors have proposed using the term 
“May-Thurner anatomy” in patients without 
hemodynamic significance and reserve the term “May-
Thurner syndrome” for cases with compromised venous 
flow [9]. 
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Fig.1: drawing showing left common iliac vein 
compression by right common iliac artery  
(morphologic type I).  
 
 
II.  METHODOLOGY 
 
Clinical Manifestations 
MTS usually presents in the second or third decade of life 
and is more common in women. The majority of these 
patients are asymptomatic. Once symptoms develop, 
patients can present during the acute or chronic MTS 
phase. Patients with acute manifestations most frequently 
(18-49% of cases) present with unilateral left lower LCIV 
thrombosis, swelling and pain [10]. Prolonged 
immobilization, dehydration, multiple pregnancies, the 
postpartum period, contraceptive therapy, surgical 
intervention for gynaecologic [11] and abdominal 
pathologic conditions [12] or febrile illness, including 
pneumonia and pleurisy [13,14,15], have been described 
as the main risk factors.  
Acute MTS can be life-threatening if there is a 
spontaneous retroperitoneal hematoma associated with 
iliac vein rupture [16,17] or an associated pulmonary 
embolism (PE). However, it should be pointed out that 
these patients rarely present with PE probably because 
ilio-caval compression may offer protection by trapping 
large emboli [18]. Chronic MTS is the result of long-term 
venous hypertension and is characterized by chronic 
venous insufficiency (CVI), varicose veins, lower-
extremity skin pigmentation changes 
(lipodermatosclerosis), chronic leg pain, recurrent skin 
ulcers [14], phlegmasia cerulea dolens [19], or recurrent 
superficial venous thrombophlebitis. Other MTS 
presentations include cryptogenic stroke in patients with a 
patent foramen ovale [20,21], pelvic congestion syndrome 




Fig.2: drawing showing diffuse atrophy of left common 
iliac vein in May-Thurner Syndrome  
(morphologic type II).  
 
Diagnostic techniques 
Clinical information alone (history and physical 
examination) is insufficient for the diagnosis of MTS. A 
thrombophilia workup should always be performed to 
identify the risk factors for DVT, specifically in younger 
patients, and objective diagnostic testing is essential. 
Non-invasive imaging modalities useful in the evaluation 
of MTS include color Doppler ultrasound, Computed 
Tomography (CT), Magnetic Resonance Imaging (MRI) 
and Intravascular Ultrasound (IVUS), while a useful 
invasive diagnostic test is contrast venography. 
 
Color Doppler Ultrasound  
The potential pitfalls of each of these diagnostic 
modalities must be recognized to avoid false 
interpretation. Over the years, because of its wide 
availability, portability and cost-effectiveness, ultrasound 
has been routinely used in the first-line evaluation of MTS 
patients, as it allows for a correct evaluation of the status 
of the deep veins of the extremity involved. 
However the accuracy of ultrasonography in patients with 
MTS is not very convincing because of its lower 
sensitivity above the inguinal plane [24,19].  
When visualization of the common iliac vein is possible, 
MTS may be diagnosed with trans-abdominal color 
Doppler ultrasound [25], but the overall sensitivity of US 
in visualization of the external iliac vein and common iliac 
vein is reportedly 79% and 47%, respectively [26]. If 
MTS is suspected in patients following ultrasound, cross-
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Fig.3: drawing showing cordlike obliteration of left 
common iliac vein in May-Thurner Syndrome 
(morphologic type III) 
 
In 2007 Labropoulos et al. [27] determined the following 
ultrasound criteria to detect a clinically substantial vein 
obstruction: 
 Color flow demonstrates mosaic flow, indicating 
post-stenotic turbulence due to proximal venous 
stenosis; 
  Pulse Doppler discloses absence of flow at the 
area of stenosis; 
 Continuous flow (absence of phasic blood blow); 
  Abnormal Valsalva response with continuous 
flow during Valsalva maneuver; 
 A peak vein velocity ratio of >2.5 across the 
stenosis. 
 
Computed Tomography and Magnetic Resonance Imaging 
CT and MRI, as compared with ultrasonography, yield 
markedly higher accuracy values.  
There is no consensus about specific radiological signs 
however the most useful findings are: 
 Compression of the left common iliac vein by the 
right common iliac artery 
 Tortuous venous collaterals crossing the pelvis to 
drain into the contralateral veins 
 Thrombus formation.  
Both CT and MRI have high sensitivity and specificity in 
the identification of DVT [28,29,30] of the venous 
compression and pelvic venous collaterals.  
CT, particularly with a standardized protocol, is useful for 
a fast, comprehensive evaluation of the vascular system. 
[14]. Jeon et al. in 2010 investigated the potential role of 
CT venography by analyzing the morphologic features in 
predicting endovascular technical difficulties (fibrotic 
stenosis increase stent insertion) and long-term stent 
patency [31]. Three morphologic types of MTS have been  
individuated, each representing different stages of the 
obstruction: focal extrinsic compression, diffuse atrophy 
and cordlike obliteration, (Fig. 1,2,3). 
 The MRI, instead, permits accurate estimation of venous 
compression, length of obstruction and collateral vein 





Fig.4a: MRI of 18 year-old women showing compression 
and thrombotic occlusion of the left iliac vein  
The recent blood pool contrast agent “gadofosveset 
trisodium” has increased imaging resolution, sensitivity, 
specificity and accuracy versus the non-enhanced MR 
angiography and has not been shown to cause nephrogenic 
systemic fibrosis [32,33].   
 
Intravascular Ultrasound  
Intravascular US (IVUS) has been used successfully to 
demonstrate iliac vein compression. It allows assessment 
of the intimal changes, mural abnormalities (spurs), 
intraluminal webs and channels in the vessel wall and can 




The gold standard diagnostic test is contrast venography, 
but it is invasive, expensive, and the contrast can cause 
allergic reactions or post-injection DVT. Venography with 
the use of trans-venous pressure measurements is 
considered the modality of choice for diagnosing MTS.   
Simultaneous pressure measurements in both external iliac 
veins should be obtained. Normally the pressure is 5 to 6 
mm Hg at rest while during exercise it measures 7 mm 
Hg. To diagnose a significant stenosis, the resting 
pressure gradient between the 2 iliac veins should be 
greater than 2 mm Hg at rest and greater than 3 mm 
Hg during exercise. Other authors measured the 
pressure in the lower inferior vena cava above the site 
of obstruction and performed pullback pressure 
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studies and found these methods more valid than the 
above measurements [37]. 
 
Advantages and disadvantages of US, CT, MRI, IVUS 






Fig.4b: Subtracted maximum intensity  
projection coronal post contrast MRI showing  
dilated left pelvic collaterals. 
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Table I: Techniques for the diagnosis of May-Thurner syndrome
 Advantages Disadvantages 
ULTRASOUND Highly sensitive and specific for proximal 
lower extremity DVT 
 
Least expensive imaging method  
 
Non-invasive, portable, can be done at 
patient’s bedside 
 
Non-ionizing radiation hazards, hence ideal 
for young women 
 
Low sensitivity above the inguinal plane 
[25] 
 
Iliac vein thrombosis may be technically 
challenging to depict [25] 
 
Iliac vein compressibility may not be 




Pain, bandages, or casts may limit or 
prevent examination 
 
CT  Non operator dependent 
 
High sensitivity and specificity 
 
MDCT allows multiplanar reconstruction of 
images with exquisite details 
 
More readily available and approachable 
compared to MRI 
 
Less expensive compared to MRI 
 
Radiation exposure  
 
Large volume of contrast agent required to 
achieve opacification of veins 
 
Contrast agent toxicity 
 
Limited resolution in the pelvic region due 






Non operator dependent 
 
Better contrast resolution 
 
Non-ionizing radiation hazards, hence ideal 
for young women 
 
Direct multiplanar imaging 
 
Better safety profile of gadolinium-based 
contrast agents 
 
Useful in assessing the haemodynamic 
significance of venous compression as it 
has the ability to demonstrate retrograde 
flow [25,38,39] 
 
Contraindicated for patients with 
pacemakers and other metallic implants 
 




Metallic implant in the pelvis can create 
imaging artifacts 
IVUS Most sensitive and dynamic test to 
determine the degree of stenosis and to 
calibrate vessel before stent deployment 
 
During endovascular treatments facilitates 





Does not yield extra-vascular information 
CATHETER 
VENOGRAPHY 
Allows the assessment of haemodynamic 
Significance 
 
Allows treatment in the same setting 
 
Pressure gradients could be measured 






Can cause allergic reactions or post-
injection DVT 
 
Does not yield extra-vascular information 
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Treatment 
Treatment dependents on the presence of DVT [40]: 
 in the absence of DVT, conservative treatment is 
preferred; 
 in the presence of DVT, the standard therapy is 
anticoagulation with compression bandages.  
Management strategies for the treatment of MTS are 






















































Historically, the treatment for MTS patients has been 
anticoagulation therapy. Although anticoagulation 
prevents clot propagation, the existing clot and the 
underlying mechanical compression persist. 
Consequently, anticoagulation alone and thrombectomy 
with prospective anticoagulation yielded a recurrent 




Table II: Flow-chart of May-Thurner syndrome management 
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Surgical Management 
Surgical management can be offered with different 
surgical treatment methods. (Fig. 5).  
Today, MTS patients rarely undergo surgery management 
because endovascular techniques have been shown to have 
fewer operative risks [43,44]. For this reason, to date, the 







Fig.5: drawing showing Palma operation with autologous 
saphenous vein graft 
 
Endovascular Management 
Endovascular management should be the first-line 
treatment for MTS as demonstrated by retrospective and 
prospective studies [34,45,46,15,47]. Endovascular 
management typically begins with venography to confirm 
MTS and demonstrate the degree of LCIV stenosis 
followed by a percutaneous transluminal angioplasty 
(PTA) to expand the intraluminal space and finally the 
implantation of a self-expanding stent (Fig.6). 
Some topics remain highly controversial:  
 The use of IVC filters. 
If DVT is present, some practitioners suggest that a IVC 
filter should be placed [48,49].  
However, recent Society for Vascular Survey (SVS) 2012 
guidelines [50] do not recommend the placement of an 
IVC filter given the known long-term complications 
associated with IVC filters and the low risk for PE events 
of MTS. 
 Pharmacomechanical thrombolysis versus full 
anticoagulation alone. 
SVS guidelines suggest the benefit of early intervention 
with percutaneous thrombolysis [50] while the American 
College of Chest Physicians guidelines suggest, instead, 
full anticoagulation alone over regional, systemic, or 
mechanical thrombolysis [51].  
Some respected authorities today include staged 
thrombolysis in the treatment of MTS, especially in the 
presence of extensive iliofemoral DVT [52-56] 
 The superiority of a particular endovascular 
combination in long-term primary patency 
Today it is well established that stent placement has 
higher patency rates than angioplasty [42] and that 
stainless steel stents are to be preferred to high radial force 
stents [57]. Brazeau et al. [58] examined various 
treatments but no specific treatment has yet demonstrated 
better outcomes.  
 Type of stent 
As above-mentioned, ilio-femoral venous stenting is now 
the primary treatment option for occlusions of the venous 
outflow tract. Today stenting has definitively replaced the 
open procedures that were utilized in the past and is often 
performed after pharmacological or mechanical thrombus 
removal. The first results of ilio-femoral venous stenting 
were reported during the early 1990s [59]. Since then 
technology in stent design has much improved. Zilver 
vena (Cook Medical, Bloomington, IN, USA) is one of the 
most recent stents on the market designed specifically for 
this purpose. It is a self-expandable nitinol stent that 
provides flexibility, consistent radial force and continuous 
stent to vein wall apposition from end to end. Zilver vena 
is currently available in 14 and 16 mm diameters and 
60,100 and 140 mm lengths. Most often, this type of stent 
is delivered from the IVC to approximately the level of 
the lesser trochanter. Post-dilatation is usually performed 
up to the nominal diameter of the stent [60].   
 
        
 
 
Fig.6: drawing showing endovascular treatment with self-
expanding stent placement in left common iliac vein 
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III. CONCLUSION 
 
May-Thurner syndrome is a relatively rare entity and 
therefore knowledge of this syndrome associated with 
deep veins is essential. The aim of this study is to present, 
in a very didactic form, current management of this 
disorder, including diagnostic and interventional 
strategies.  Endovascular techniques have evolved and 
now play a significant role in the treatment of May-
Thurner syndrome. In the majority of individuals with 
May-Thurner syndrome it is believed that direct 
compression of the left iliac vein between the right iliac 
artery and fifth lumbar vertebrae predisposes to the 
formation of deep vein thrombi. The syndrome is thought 
to progress through 3 stages: (1) asymptomatic 
compression of the vein, (2) the development of 
intraluminal spurs (fibrous bands) at the site of 
compression and (3) development of deep vein thrombi. 
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